Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Clovis's Rubraca Leapfrogs Rivals In Ovarian Cancer As ARIEL3 Hits

Jun 19 2017

• By Alex Shimmings

Mermaid — ARIEL seeks a new world of patients for Rubraca • Source: Shutterstock

Related Content

Broad Label Gives Tesaro's Niraparib A Head Start In Ovarian Cancer

Mar 28 2017

AstraZeneca's Lynparza Looks To Hang On To Lead, With Tesaro's Niraparib On The Way

Mar 14 2017

Related Companies

Clovis Oncology, Inc.

AstraZeneca PLC

Tesaro, Inc.

AbbVie Inc.

Additional Topics

Clinical Trials Companies Research & Development Cancer BioPharmaceutical

More from Clinical Trials

More from R&D

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.